Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists

BACKGROUND: Positron emission tomography (PET) imaging is routinely used in many cancer types, although is not yet a standard modality for prostate carcinoma. Prostate-specific membrane antigen (PSMA) PET is a promising new modality for staging prostate cancer, with recent studies showing potential...

Descripción completa

Detalles Bibliográficos
Autor principal: Shakespeare, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652371/
https://www.ncbi.nlm.nih.gov/pubmed/26582424
http://dx.doi.org/10.1186/s13014-015-0548-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652371/
https://www.ncbi.nlm.nih.gov/pubmed/26582424
http://dx.doi.org/10.1186/s13014-015-0548-8

Ejemplares similares